GSK files melanoma drug combination early in race to market
LONDON (Reuters) - GlaxoSmithKline has filed for U.S. approval of a two-drug combination against melanoma earlier than many industry analysts expected...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/QiEbCONsdAM/story01.htm
No comments:
Post a Comment